Oncolytics Biotech (ONCY) Enterprise Value (2009 - 2026)
Oncolytics Biotech (ONCY) recorded Enterprise Value of $114.29 million in Q2 2026, up 77.3% from $64.45 million a year earlier.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Enterprise Value (2009 - 2026) Analysis & Trends
On a TTM basis, Oncolytics Biotech's Enterprise Value came in at $89.56 million as of Jun 30, 2026, up 219.8% year-over-year; for FY2025, it was $88.78 million, up 45.1% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of 0.5% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $61.17 million in FY2024 (-18.0%), $74.6 million in FY2023 (-0.9%), $75.25 million in FY2022 (+72.6%) and $43.59 million in FY2021 (-49.7%).
- Quarterly Enterprise Value has ranged from $29.17 million in Q2 2022 to $141.32 million in Q2 2023 over the past five years.
- On a year-over-year basis, Enterprise Value rose in four of the last seven quarters, with growth averaging 25.7%.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 384.5% in Q2 2023, against a decline of 66.3% in Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn |
| 10 | Oncolytics Biotech | 60.72 Mn | 31.84 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 114.29 Mn |
| Dec 31, 2025 | 88.78 Mn |
| Sep 30, 2025 | 127.50 Mn |
| Jun 30, 2025 | 64.31 Mn |
| Mar 31, 2025 | 33.32 Mn |
| Dec 31, 2024 | 61.71 Mn |
| Sep 30, 2024 | 50.24 Mn |
| Jun 30, 2024 | 55.54 Mn |
| Mar 31, 2024 | 57.02 Mn |
| Dec 31, 2023 | 74.08 Mn |
| Sep 30, 2023 | 104.06 Mn |
| Jun 30, 2023 | 141.07 Mn |
| Mar 31, 2023 | 51.65 Mn |
| Dec 31, 2022 | 76.25 Mn |
| Sep 30, 2022 | 44.04 Mn |
| Jun 30, 2022 | 29.44 Mn |
| Mar 31, 2022 | 55.34 Mn |
| Dec 31, 2021 | 44.13 Mn |
| Sep 30, 2021 | 58.78 Mn |
| Jun 30, 2021 | 86.90 Mn |
API Access
Oncolytics Biotech Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();